학술논문

Evolving management strategies in head and neck paragangliomas: A single‐centre experience with 147 patients over a 60‐year period.
Document Type
Article
Source
Clinical Otolaryngology. Sep2019, Vol. 44 Issue 5, p836-841. 6p.
Subject
*PARAGANGLIOMA
*NECK
*CAROTID body
*OTOSCOPY
*CHROMAFFIN cells
Language
ISSN
1749-4478
Abstract
Evolving management strategies in head and neck paragangliomas: A single-centre experience with 147 patients over a 60-year period The interval was determined by several factors, such as tumour size, tumour progression rate, tumour localisation, symptoms and treatment modality, and thus differed per tumour and per patient. Two of these patients (2/29; 7%) were diagnosed with a concurrent PHEO, one of these patients was diagnosed with metastatic disease (1/29; 3%), and 2 (2/29; 7%) patients were diagnosed with a sPGL. As different treatment strategies may apply different tumour locations within one patient, a single treatment strategy could not be associated with a patient with multiple HNPGLs. [Extracted from the article]